Citations for
1ARL11
ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.
Siltanen S, Syrjäkoski K, Fagerholm R, Ikonen T, Lipman P, Mallott J, Holli K, Tammela TL, Järvinen HJ, Mecklin JP, Aittomäki K, Blomqvist C, Bailey-Wilson JE, Nevanlinna H, Aaltonen LA, Schleutker J, Vahteristo P.
Eur J Hum Genet 16(8):983-91. Epub 2008 Mar 12. 2008
2ARL11
ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.
Siltanen S, Syrjäkoski K, Fagerholm R, Ikonen T, Lipman P, Mallott J, Holli K, Tammela TL, Järvinen HJ, Mecklin JP, Aittomäki K, Blomqvist C, Bailey-Wilson JE, Nevanlinna H, Aaltonen LA, Schleutker J, Vahteristo P.
Eur J Hum Genet ur J Hum Genet. 2008 2008
3ARL11
Tumor suppressor functions of ARLTS1 in lung cancers.
Yendamuri S, Trapasso F, Ferracin M, Cesari R, Sevignani C, Shimizu M, Rattan S, Kuroki T, Dumon KR, Bullrich F, Liu CG, Negrini M, Williams NN, Kaiser LR, Croce CM, Calin GA.
Cancer Res 67(16):7738-45. 2007
4ARL11
Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.
Frank B, Hemminki K, Meindl A, Wappenschmidt B, Klaes R, Schmutzler RK, Untch M, Bugert P, Bartram CR, Burwinkel B.
Int J Cancer 118(10):2505-8. 2006
5ARL11
Familial cancer associated with a polymorphism in ARLTS1.
Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK, Ferracin M, Bernardi G, Chatterjee D, Baldassarre G, Rattan S, Alder H, Mabuchi H, Shiraishi T, Hansen LL, Overgaard J, Herlea V, Mauro FR, Dighiero G, Movsas B, Rassenti L, Kipps T, Baffa R, Fusco A, Mori M, Russo G, Liu CG, Neuberg D, Bullrich F, Negrini M, Croce CM.
N Engl J Med 352(16):1667-76. 2005